Schematic graph illustrating the TGFB/Smad signaling pathway and its roles in the regulation of various biological processes during chronic kidney disease
Schematic graph illustrating the TGF-β/Smad signaling pathway and its roles in the regulation of various biological processes during chronic kidney disease. TGF-β ligands, initially synthesized as latent forms, bind to TGF-βRII upon release. This interaction recruits and activates TGF-βRI, leading to the phosphorylation of intracellular Smad2/3. Subsequently, phosphorylated Smad2/3 forms a complex with Smad4, which then translocates to the nucleus to regulate gene transcription. Conversely, Smad7 disrupts TGF-β signaling by competing with Smad2/3 for TGF-βRI and facilitating TGF-βRII degradation. Red arrows or symbols denote pathogenic mechanisms or pathways of positive regulation, whereas blue lines or symbols signify protective mechanisms or pathways of negative regulation. TGF, transforming growth factor; TGF-βR, TGF-β receptor; TEC, tubular epithelial cell; Mφ, macrophage; ENT, endothelial cells; FSP, fibroblast; Arid2-IR, AT-rich interaction domain 2 intronic transcript; MCP-1, macrophage chemotactic protein-1; iNOS, inducible nitric oxide synthase; MMP-12, matrix metalloproteinase-12; Foxp3, forkhead box P3; RORγt, retinoid acid receptor-related orphan receptor γt